Page 819 - ACCCN's Critical Care Nursing
P. 819
796 I N D E X
bundle of His 184–185 atrial 269, 269f IABP 550
burns 644 AV block and 269, 270f inotropic therapy for 548–550, 549t
airway and 647 capture and 267, 267f preload 548
breathing and 648 cardiac resynchronization therapy 279–280 respiratory support 550
circulation and 648 capturing failure recognition in 280, 281f haemodynamic change sequence in 547f
dressing for 648–649 non responders to 279–280 independent practice in 548
hyperkalaemia and 648 programming optimisation 280 assessment 548
hypothermia minimisation and 648 complications of 272–275 oxygen supply and demand
inhalation injury 645–646 capture failure 272, 272f optimisation 548
multitrauma patient 648 oversensing 274–275, 274f, 275b nursing practice in 548–551
nursing care after 647t pacing failure 273–274, 274b, 274f cardiomyopathy 241–242
nutrition and 648 sensing failure 272–273, 273f dilated 241
pathophysiology of 644–649 controls and settings 266, 267t hypertrophic 241–242
specialised centre treatment criteria 645b demand 268, 268f peripartum 725–726
systemic changes and 645t dual-chamber 269–272, 271f restrictive 242
TBSA assessment 646 DDD 270–272, 271f cardiopulmonary bypass (CPB) 294–295
BURP see backwards, upwards, rightward external 272 cardiopulmonary resuscitation (CPR) 655, 784
pressure manoeuvre nursing practice 275–277 for adults 659t
business case development 21–22, 21t battery depletion 275–276 ceasing 671
heading samples 22b function testing 276–277, 276f–277f for children 659t
microshock protection 275 do-not-resuscitate orders 87
C output and threshold 267 ethical considerations and 672
permanent 277–279
evaluation during 670
CABG see coronary artery bypass graft implantation activities 278 family presence during, research
CACCN see Canadian Association of Critical parameters 278–279, 278f vignette 174b–175b
Care Nurses principles of 265–266 for infants 659t
cadaveric donor 784 terminology 266–269, 267t in-hospital survival from 655
CAM-ICU see Confusion Assessment Method for ventricular 268–269, 269f legal considerations and 672
the Intensive Care Unit cardiac rehabilitation 226–227 out-of-hospital survival from 655
Canadian Association of Critical Care Nurses cardiac resynchronization therapy (CRT) postresuscitation phase 671
(CACCN) 27 279–280 cardiotocograph 732
CAP see community-acquired pneumonia capturing failure recognition in 280, 281f cardiovascular system
capillaries 189, 189f non responders to 279–280 anatomy of 180–190
capital budget 20 programming optimisation 280 assessment of 190–195
capnography 340–341, 341f, 386, 784 cardiac surgery 291–302 case study 210b–211b
capture failure 272, 272f case study 320b for CHF 231
case study 256f–258f, 285b–286b massage therapy postoperatively, research heart sounds auscultation 191–192, 191t
carbon dioxide (CO 2 ) vignette 321b pulse 190–191
narcosis 381–382 nursing management postoperatively blood pressure see blood pressure
transport 332 295–302 cardiac output 185–189
carbon monoxide (CO) poisoning 603 arrhythmias 297 determinants of 185–188, 186f
cardiac allograft vasculopathy (CAV), post heart bleeding assessment and regulation of 188–189
transplantation 317–318 management 298–300 in children 681–682
cardiac arrest 784 emotional responses 302 continuous monitoring of 192
see also sudden cardiac arrest family support 302 diagnostic tests for 206–210
cardiac biopsy grading 313t fluid and electrolyte management 302 blood tests 206–207
cardiac computed tomography 209–210 haemodynamic monitoring and cardiac CT 209–210
cardiac conduction system 184–185, 185f, support 296–297 cardiac enzymes 206–207, 208t
251–252 hypertension 296 chest x-ray 207–209
arrhythmogenic mechanisms 252 hypotension 296–297 echocardiography 206
abnormal automaticity 252 immediate period 295–296 electrolytes 206, 208t
reentry 252 pain assessment and management 302 full blood count 206
triggered activity 252 pericardial tamponade assessment and MRI 209–210
cardiac cycle 187–188, 187f management 300–301 nuclear medicine studies 209–210
cardiac death, donation after 785 rhythm monitoring 297 haemodynamic monitoring
cardiac enzymes 206–207, 208t ventilatory support 298, 299t invasive cardiovascular monitoring see
cardiac failure see heart failure procedures 293–295 invasive cardiovascular monitoring see
cardiac glycosides, for CHF 238t, 240 CABG 293–294 haemodynamic monitoring
cardiac macrostructure 180–182 CPB 294–295 liver transplantation and 524
conduction and 184–185 myocardial preservation 295 macrostructure 180–182
cardiac muscle, electron micrograph of valve repair and replacement 294, 295f conduction and 184–185
181–182, 182f for structural abnormalities 291–293 physiological principles 182–185
cardiac output (CO) 185–189, 203–206 aortic valve disease 292–293 action potential 183–184, 184f
decreased, lung transplantation and 371t ischaemic heart disease 293 depolarisation 183–184
determinants of 185–188, 186f mitral valve disease 293 mechanical events of contraction 182–183
Doppler ultrasound methods 204–205, valvular disease 291–293, 292f resting potential 183–184
205f cardiac tamponade, post heart pregnancy and 727–729
Fick principle 203 transplantation 315, 318t pregnancy physiology adaptation in 711–713,
pregnancy and 712 cardiac trauma 636 712t
pulse-induced contour 203–204, 204f cardiac troponin I (cTnI) 218–219 anatomical changes 711
regulation of 188–189 cardiac troponin T (cTnT) 218–219 blood pressure 712
thermodilution methods 203 cardiogenic shock 227, 545–551 blood volume 711–712
transthoracic bioimpedance 205–206 clinical manifestations of 546–548 cardiac output 712
ultrasonic cardiac output monitor 205 collaborative management of 548–550 heart rate 712
cardiac pacing 265–280, 784 afterload control 550 postpartum 712–713
asynchronous 268 biochemical normalisation 550–551 posture on haemodynamics 712

